Skip to main content

Oncology Startups

Updated October 2026

Companies in the oncology sector developing innovative solutions and technologies.

Explore 311 recently funded oncology companies with verified founder contact information and fundraising data.

Total Companies
311
Total Funding
$1.5B
Avg Funding
$61.8M
Global Reach
9
countries

Top Cities for Oncology

Carlsbad
Bellaire
San Francisco
Geleen
Prague
New York

Recently Funded Companies

Export
Carlsbad, United States

View Point Medical is a medical device and technology company developing tissue markers that enable lesion localization in cancer care.

$3.8M raised
Jan 2024

Founder Contacts

41,000+ verified contacts

Bellaire, United States

Oncology Health Partners provides oncology care coordination, clinical support, and treatment delivery services for cancer patients.

$15.0M raised
Dec 2024

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Launchpad Therapeutics operates as an antibody-focused precision oncology company.

$10.0M raised
Dec 2022

Founder Contacts

41,000+ verified contacts

Geleen, The Netherlands

Temple Therapeutics creates and develops therapies for orthopedics, oncology, and endometriosis patients.

$325K raised
Dec 2023

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Trial Library is an oncology clinical trials company.

$10.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Prague, Czech Republic

Sotio is a biotechnology company developing a new immunotherapy based on activated dendritic cells for the treatment of cancer.

$316.6M raised
Dec 2021

Founder Contacts

41,000+ verified contacts

New York, United States

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

$14.4M raised
Dec 2023

Founder Contacts

41,000+ verified contacts

London, United Kingdom

VIVAN Therapeutics is a company pioneering personalized cancer therapeutics using a new assay technology.

Dec 2022

Founder Contacts

41,000+ verified contacts

Würzburg, Germany

T-CURX develops personalized T cell therapies for cancer, leveraging a proprietary platform for improved patient outcomes.

$20.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

New York, United States

Promontory Therapeutics is a clinical-stage pharmaceutical company focused on novel therapeutics in oncology.

$37.0M raised
Dec 2021

Founder Contacts

41,000+ verified contacts

Lyon, France

ErVimmune develops cancer vaccines and T cell therapies targeting cold tumors using AI-driven antigen discovery.

$19.9M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Cheshunt, United Kingdom

HQ Science is a biotechnology company at the forefront of molecular diagnostics innovation.

$264K raised
Dec 2024

Founder Contacts

41,000+ verified contacts

Irvine, United States

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

$238.0M raised
Dec 2024

Founder Contacts

41,000+ verified contacts

Nerviano, Italy

Nerviano Medical Sciences is a provider of R&D services include oncology drug discovery, preclinical research, clinical development.

$220.9M raised
Jan 2022

Founder Contacts

41,000+ verified contacts

San Diego, United States

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

$84.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Houston, United States

Diakonos Oncology biotech firm developing dendritic cell vaccines targeting difficult cancer types.

$7.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Boston, United States

Regor Therapeutics is an international biotech company that focuses in the therapeutic areas of oncology, metabolic and autoimmune diseases.

$50.0M raised
Dec 2021

Founder Contacts

41,000+ verified contacts

Chester, United Kingdom

Canton Strategic Holdings drives institutional blockchain adoption via the Canton Network, digital assets, and market digitization.

$55.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Toronto, Canada

Telo Genomics, a biotech company that offers telomere platform for biopsies and related technologies in oncology and neurological diseases.

$1.2M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Geel, Belgium

DeuterOncology is a preclinical-stage biotech company.

$6.1M raised
Jan 2023

Founder Contacts

41,000+ verified contacts

Tempe, United States

Calviri provides cancer treatment products by combining the immunogenic source of neoantigens with a peptide array platform.

$785K raised
Nov 2024

Founder Contacts

41,000+ verified contacts

San Diego, United States

Certis Oncology Solutions is a precision oncology and translational science company serving patients, oncologists and drug developers

$10.0M raised
Jan 2024

Founder Contacts

41,000+ verified contacts

Redwood City, United States

Guardant Health is a precision oncology company that uses blood tests, data sets, and analytics to provide treatment to cancer patients.

$350.0M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Houston, United States

At Speratum, we're developing a robust RNAi platform targeting key oncogenic drivers in solid tumors.

$581K raised
Nov 2024

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

Neok Bio is a biotech startup that focuses on bispecific ADCs in cancer therapy.

$75.0M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Showing 251 to 275 of 311 companies

About the Oncology Startup Ecosystem

The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Oncology

Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Oncology Funding Breakdown

Here is how funding is distributed among the 311 oncology companies tracked in the VCBacked database.

Average Funding
$61.8M
Total Funding Tracked
$1.5B
Countries Represented
9

Distribution by Funding Stage

Other25 companies

Top Cities for Oncology

1.San Francisco
2 companies$20.0M
2.New York
2 companies$51.4M
3.San Diego
2 companies$94.0M
4.Houston
2 companies$7.6M
5.Carlsbad
1 companies$3.8M

Related Industries

Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Oncology Startups?

Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked